Literature DB >> 23361414

What justifies the United States ban on federal funding for nonreproductive cloning?

Thomas V Cunningham1.   

Abstract

This paper explores how current United States policies for funding nonreproductive cloning are justified and argues against that justification. I show that a common conceptual framework underlies the national prohibition on the use of public funds for cloning research, which I call the simple argument. This argument rests on two premises: that research harming human embryos is unethical and that embryos produced via fertilization are identical to those produced via cloning. In response to the simple argument, I challenge the latter premise. I demonstrate there are important ontological differences between human embryos (produced via fertilization) and clone embryos (produced via cloning). After considering the implications my argument has for the morality of publicly funding cloning for potential therapeutic purposes and potential responses to my position, I conclude that such funding is not only ethically permissible, but also humane national policy.

Entities:  

Mesh:

Year:  2013        PMID: 23361414     DOI: 10.1007/s11019-013-9465-5

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  29 in total

Review 1.  Embryoid bodies: an in vitro model of mouse embryogenesis.

Authors:  I Desbaillets; U Ziegler; P Groscurth; M Gassmann
Journal:  Exp Physiol       Date:  2000-11       Impact factor: 2.969

Review 2.  Nuclear transplantation, embryonic stem cells, and the potential for cell therapy.

Authors:  Konrad Hochedlinger; Rudolf Jaenisch
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

Review 3.  Fetal pain: a systematic multidisciplinary review of the evidence.

Authors:  Susan J Lee; Henry J Peter Ralston; Eleanor A Drey; John Colin Partridge; Mark A Rosen
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

4.  Moral status, human identity, and early embryos: a critique of the President's approach.

Authors:  David DeGrazia
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

5.  What has bioethics to offer health policy?

Authors:  D Wikler
Journal:  Milbank Q       Date:  1991       Impact factor: 4.911

6.  US public policy on embryo research: two steps forward, one large step back.

Authors:  J C Fletcher
Journal:  Hum Reprod       Date:  1995-07       Impact factor: 6.918

7.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 8.  Model systems for studying trophoblast differentiation from human pluripotent stem cells.

Authors:  Toshihiko Ezashi; Bhanu Prakash V L Telugu; R Michael Roberts
Journal:  Cell Tissue Res       Date:  2012-03-17       Impact factor: 5.249

Review 9.  Embryonic stem cells and tissue engineering: delivering stem cells to the clinic.

Authors:  A Vats; N S Tolley; A E Bishop; J M Polak
Journal:  J R Soc Med       Date:  2005-08       Impact factor: 18.000

10.  Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences.

Authors:  Simon R Smukler; Susan B Runciman; Shunbin Xu; Derek van der Kooy
Journal:  J Cell Biol       Date:  2006-01-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.